A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This is up to a 58 week study comparing ferric citrate to active control for 52 weeks in ESRD
dialysis patients, and subsequently comparing ferric citrate to placebo for 4 weeks.